Xuesaitong soft capsule

DRUG3 trials

Sponsors

Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Jie Wang, China National Center for Cardiovascular Diseases

Conditions

Blood Stasis SyndromeCoronary Heart DiseaseUnstable Angina

Phase 2

The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease

Guang'anmen Hospital of China Academy of Chinese Medical SciencesBlood Stasis Syndrome, Coronary Heart Disease, Unstable Angina

Start: 2012-05-31End: 2014-12-31Target: 70Updated: 2014-01-14

Efficacy and Safety of Xuesaitong Soft Capsule for Coronary Heart Disease Unstable Angina

Jie WangCoronary Heart Disease, Unstable Angina

Start: 2017-03-20End: 2017-08-20Target: 70Updated: 2017-03-17

Phase 4

Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease

RecruitingNCT06425120

China National Center for Cardiovascular DiseasesCoronary Heart Disease

Start: 2024-06-01End: 2026-12-31Target: 240Updated: 2025-09-08

Related Papers

Panax notoginseng Saponins Alleviate Coronary Artery Disease Through Hypermethylation of the miR-194-MAPK Pathway

Frontiers in Pharmacology2022-06-1613 citations